Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants

Shuijing Wang; Yan Yu; Paul M. Ryan; Minyan Dang; Cain Clark; Vasileios Kontogiannis; Jamal Rahmani; Hamed Kord Varkaneh; Ammar Salehisahlabadi; Andrew S. Day; Yong Zhang

doi:10.1016/j.phrs.2019.104585

Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants

Shuijing Wang
, Yan Yu
, Paul M. Ryan
, Minyan Dang
, Cain Clark
, Vasileios Kontogiannis
, Jamal Rahmani
, Hamed Kord Varkaneh
, Ammar Salehisahlabadi
, Andrew S. Day
, Yong Zhang^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

43 Citations (SciVal)

Original language	English
Article number	104585
Journal	Pharmacological Research
Volume	151
DOIs	https://doi.org/10.1016/j.phrs.2019.104585
Publication status	Published (VoR) - Jan 2020

Keywords

Aspirin
Hepatocellular carcinoma
Liver cancer

Access to Document

10.1016/j.phrs.2019.104585

Cite this

Wang, S., Yu, Y., Ryan, P. M., Dang, M., Clark, C., Kontogiannis, V., Rahmani, J., Varkaneh, H. K., Salehisahlabadi, A., Day, A. S., & Zhang, Y. (2020). Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants. Pharmacological Research, 151, Article 104585. https://doi.org/10.1016/j.phrs.2019.104585

@article{780368d0fb3945fd9e2969e189456ffd,

title = "Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants",

keywords = "Aspirin, Hepatocellular carcinoma, Liver cancer",

author = "Shuijing Wang and Yan Yu and Ryan, \{Paul M.\} and Minyan Dang and Cain Clark and Vasileios Kontogiannis and Jamal Rahmani and Varkaneh, \{Hamed Kord\} and Ammar Salehisahlabadi and Day, \{Andrew S.\} and Yong Zhang",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2020",

month = jan,

doi = "10.1016/j.phrs.2019.104585",

language = "English",

volume = "151",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Elsevier",

}

Wang, S, Yu, Y, Ryan, PM, Dang, M, Clark, C, Kontogiannis, V, Rahmani, J, Varkaneh, HK, Salehisahlabadi, A, Day, AS & Zhang, Y 2020, 'Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants', Pharmacological Research, vol. 151, 104585. https://doi.org/10.1016/j.phrs.2019.104585

TY - JOUR

T1 - Association of aspirin therapy with risk of hepatocellular carcinoma

T2 - A systematic review and dose-response analysis of cohort studies with 2.5 million participants

AU - Wang, Shuijing

AU - Yu, Yan

AU - Ryan, Paul M.

AU - Dang, Minyan

AU - Clark, Cain

AU - Kontogiannis, Vasileios

AU - Rahmani, Jamal

AU - Varkaneh, Hamed Kord

AU - Salehisahlabadi, Ammar

AU - Day, Andrew S.

AU - Zhang, Yong

PY - 2020/1

Y1 - 2020/1

KW - Aspirin

KW - Hepatocellular carcinoma

KW - Liver cancer

UR - https://www.scopus.com/pages/publications/85076294424

UR - https://www.scopus.com/pages/publications/85076294424#tab=citedBy

U2 - 10.1016/j.phrs.2019.104585

DO - 10.1016/j.phrs.2019.104585

M3 - Review article

C2 - 31816436

AN - SCOPUS:85076294424

SN - 1043-6618

VL - 151

JO - Pharmacological Research

JF - Pharmacological Research

M1 - 104585

ER -

Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants

Keywords

Access to Document

Other files and links

Fingerprint

Cite this